JPRN-UMIN000041422已完成未知
A histological cohort study to assess the safety and effectiveness of olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer - JGOG3026 RESPONSE study
Japanese Gynecologic Oncology Group (JGOG)0 个研究点目标入组 471 人开始时间: 2020年10月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 471
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. platinum-resistant relapsed ovarian cancer 2. stable or progressive disease after platinum-based chemotherapy for patients with platinum-sensitive relapsed ovarian cancer 3. patients who had already received a PARP inhibitor before recurrence 4. patients who received both olaparib and bevacizumab combination maintenance therapy.
研究者
相似试验
尚未招募
Unknown
To determine safety of direct discharge to home from indian intensive care units.CTRI/2024/06/068265Shikha Yadav
招募中
Unknown
Cohort Study to Evaluate the Efficacy and Safety of Postoperative Adjuvant Therapy in HER2 Positive Elderly Breast Cancer Patients with Muti-gene assayHER2 Positive Elderly Breast Cancer PatientsJPRN-UMIN000051581Public Health Research Foundation266
已完成
3 期
Cohort Study to Evaluate the Efficacy and Safety of Postoperative Adjuvant Therapy in HER2 Positive Elderly Breast Cancer PatientsHER2 positive primary breast cancer in elderlyJPRN-UMIN000028476RESPECT executive committee300
招募中
不适用
A histological cohort study fo assess the adverse events using Adspray in laparoscopic surgery for early uterine endometrial cancer.terine endometrial cancerJPRN-UMIN000041628Tokyo women's medical university300
已完成
不适用
A historical cohort study to examine the safety and efficacy of olaparib maintenance therapy after initial treatment for advanced ovarian cancerOvarian cancerJPRN-UMIN000043474Japanese Gynecologic Oncology Group (JGOG)300
